-
Angioimmunoblastic T-Cell Lymphoma (AITL) Immunoblastic Lymphadenopathy Disease - Global Clinical Trials Review, H2, 202...
Published: December, 2020 - Pages: 209 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Burkitt Lymphoma Global Clinical Trials Review, H2, 2020
Published: August, 2020 - Pages: 243 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Drug Development in Rare Diseases: Focus on Clinical Trials and the Regulatory Landscape
Published: January, 2021 - Pages: 107 - US$ 3,950.00
-
Selective Estrogen Receptor Degrader (SERDs) Market, Dosage, Price & Clinical Trials Insight 2025
Published: January, 2021 - Pages: 120 - US$ 2,400.00
COVID-19 update included[CovidUpdated]
-
Global KRAS Inhibitors Market Opportunity & Clinical Trials Outlook 2025
Published: January, 2021 - Pages: 125 - US$ 2,000.00
COVID-19 update included[CovidUpdated]
-
Arrhythmias Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 221 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Aspergillosis Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 205 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Bacterial Pneumonia Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 453 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Mycosis Fungoides Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 214 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
-
Seasonal Influenza Disease - Global Clinical Trials Review, H2, 2020
Published: December, 2020 - Pages: 163 - US$ 2,500.00
COVID-19 update included[CovidUpdated]
Would you like sample pages of this report?
US $
Euro €
GBP £